Not investment advice.Learn more
AMRX leans slightly positive on balance, but risks remain.
We couldn't find analysis data for AMRX. Please try again later.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Mid-cap company
P/E Ratio
Moderately valued
Div Yield
No dividend